News Archive
Adaptive Phage gets $10M from DoD for antibacterial phage therapies
The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria.
LEARN MORE
TEDCO reopens apps for Maryland startup funding
Maryland Technology Development Corporation (TEDCO) is once again accepting applications from startups seeking investment from several of its funds that were put on hold in the middle of 2019.
LEARN MORE
TEDCO, NIST give four companies funding
The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies for the market, TEDCO announced Tuesday.
LEARN MORE
RoosterBio, a TEDCO portfolio company, expands facility for second time in 2019
Project will support the increasing global need for “off-the-shelf” cell banks and hMSC bioprocess media products as sales continue to climb.
LEARN MORE
HeMemics Biotechnologies, Inc, a Rockville-based TEDCO portfolio company, received a $2.5 million investment from AMVI Partners
Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases
LEARN MORE
TEDCO Portfolio Company, CoapTech, in the news
'It was a life saver': New London developed device for feeding tube insertions is a world first
LEARN MORE
Machfu, a TEDCO portfolio company, raises $3.75 million to accelerate industrial IoT
CSL Ventures, Blu Ventures, Texas Ventures and Texas Halo Fund lead investment in Machfu’s technology that securely connects critical assets and sensors to modern web services
LEARN MORE
CIRM (California Institute for Regenerative Medicine) features Elixirgen Scientific on their blog
Congratulations to Carolyn Yarina of Sisu Global for being named one of Forbes Under 30 for health care!
This year, Yarina's company, Sisu Global, launched its first product designed to tackle the problem of chronic blood shortages for transfusions in certain parts of Africa. This device, called Hemafuse, can replace or augment donor blood in emergency situations. The company has won multiple awards
LEARN MORE
Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill 'Superbugs' as Part of Bear's Den Innovation Program
Hackensack Meridian Health has invested in the clinical-stage biotechnology company Adaptive Phage Therapeutics (APT), as part of the health network's successful innovation program, the Bear's Den.
LEARN MORE
MaxCyte and KSQ Therapeutics announce development & commercialization agreement to enable the advancement of KSQ’s Adoptive Cell Therapy Programs
MaxCyte, the global cell-based therapies and life sciences company, and KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to achieve higher probabilities of success in drug development, announced today that the companies have entered into a new
LEARN MORE
Five Female Investors Who Are Making Their Mark in Life Science
Arti Santhanam, Ph.D., leads TEDCO’s $5.6M MII fund, which is a program designed to propel research from partner universities towards commercialization MII has had a strong, demonstrable impact on many important life science portfolio companies in the BHCR to date.
LEARN MORE
NextStep Robotics' Brad Hennessie shares why he chose to live and grow his TEDCO portfolio company in Maryland.
Sonavex, a TEDCO portfolio company, raises $3 million, preps for national product launch
Baltimore's Sonavex Inc. has raised $3 million in new equity funding as it gears up for a nationwide launch of its medical devices.
LEARN MORE